Genetic basis for sleep regulation and sleep disorders

Seminars in Neurology

Volumn 26, Issue 5, 2006, Pages 467-483

  Raizen, David M ^a   Mason, Thornton B A ^a   Pack, Allan I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Circadian; Genetics; Homeostatic; Sleep

Indexed keywords

OREXIN;

CIRCADIAN RHYTHM; CLINICAL FEATURE; DELTA RHYTHM; ENVIRONMENTAL FACTOR; EPILEPSY; FAMILIAL ADVANCED SLEEP PHASE SYNDROME; FAMILIAL DISEASE; FATAL FAMILIAL INSOMNIA; GENE LOCUS; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HOMEOSTASIS; HUMAN; INHERITANCE; NEUROTRANSMISSION; NONHUMAN; NONREM SLEEP; PARASOMNIA; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRION DISEASE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSORIMOTOR NEUROPATHY; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP INDUCTION; SYMPTOM;

CIRCADIAN RHYTHM; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; SLEEP; SLEEP DISORDERS;

EID: 33750308030     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-951619     Document Type: Review

References (185)

1. Peirson S, Foster RG. Melanopsin: another way of signaling light. Neuron 2006;49:331-339
2. Hara R, Wan K, Wakamatsu H, et al. Restricted feeding entrains liver clock without participation of the superchiasmatic nucleus. Genes Cells 2001;6:269-278
3. Konopka RJ, Benzer S. Clock mutants of Drosophila melanogaster. Proc Natl Acad Sci USA 1971;68:2112-2116
4. Allada R, Emery P, Takahashi JS, Roshbash M. Stopping time: the genetics of fly and mouse circadian clocks. Annu Rev Neurosci 2001;24:1091-1119
5. Toh KL, Jones CR, He Y, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001;291:1040-1043
6. Jones CR, Campbell SS, Zone SE, et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999;5:1062-1065
7. Carpen JD, Archer SN, Skene DJ, Smits M, von Schantz M. A single-nucleotide polymorphism in the 5′-untranslated region of the hPER2 gene is associated with diurnal preference. J Sleep Res 2005;14:293-297
8. Xu Y, Padiath QS, Shapiro RE, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005;434:640-644
9. Czeisler CA, Duffy JF, Shanahan TL. Stability, precision, and near 24-hour period of the human circadian pacemaker. Science 1999;284:2177-2181
10. Dagan Y, Eisenstein M. Circadian rhythm sleep disorders: toward a more precise definition and diagnosis. Chronobiol Int 1999;16:213-222
11. Fukuda K. Twins under shift work: a case study of sleep log data. Percept Mot Skills 1997;84:931-937
12. Ancoli-Israel S, Schnierow B, Kelsoe J, Fink R. A pedigree of one family with delayed sleep phase syndrome. Chronobiol Int 2001;18:831-840
13. Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97-110
14. Katzenberg D, Young T, Finn L, et al. A CLOCK polymorphism associated with human diurnal preference. Sleep 1998;21:569-576
15. Robilliard DL, Archer SN, Arendt J, et al. The 3111 Clock gene polymorphism is not associated with sleep and circadian rhythmicity in phenotypically characterized human subjects. J Sleep Res 2002;11:305-312
16. Ebisawa T, Uchiyama M, Kajimura N, et al. Association of structural polymorphisms in the human periods gene with delayed sleep phase syndrome. EMBO Rep 2001;2:342-346
17. Klein T, Martens H, Jan Dijk DK, et al. Circadian sleep regulation in the absence of light perception: chronic non-24-hour circadian rhythm sleep disorder in a blind man with a regular 24-hour sleep-wake schedule. Sleep 1993;16:333-343
18. Czeisler CA. Commentary: evidence for melatonin as a circadian phase-shifting agent. J Biol Rhythms 1997;12:618-623
19. Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000;343:1070-1077
20. Hohjoh H, Takasu M, Shishikura K. Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome. Neurogenetics 2003;4:151-153
21. Borbely AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999;14:557-568
22. Van Dongen HP, Baynard MD, Maislin G, Dinges DF. Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. Sleep 2004;27:423-433
23. Leproult R, Colecchia EF, Berardi AM, Stickgold R, Kosslyn SM, Van Cauter E. Individual differences in subjective and objective alertness during sleep deprivation are stable and unrelated. Am J Physiol Regul Integr Comp Physiol 2003;284:R280-R290
24. Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic control. J Neurosci 2001;21:2610-2621
25. Hendricks JC, Finn SM, Panckeri KA, et al. Rest in Drosophila is a sleep-like state. Neuron 2000;25:129-138
26. Shaw PJ, Cirelli C, Greenspan RJ, Tononi G. Correlates of sleep and waking in Drosophila melanogaster. Science 2000;287:1834-1837
27. Hendricks JC, Kirk D, Panckeri K, Miller MS, Pack AI. Modafinil maintains waking in the fruit fly Drosophila melanogaster. Sleep 2003;26:139-146
28. Hendricks JC, Williams JA, Panckeri K, et al. A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci 2001;4:1108-1115
29. Graves LA, Hellman K, Veasey S, Blendy JA, Pack AI, Abel T. Genetic evidence for a role of CREB in sustained cortical arousal. J Neurophysiol 2003;90:1152-1159
30. Cirelli C, Bushey D, Hill S, et al. Reduced sleep in Drosophila Shaker mutants. Nature 2005;434:1087-1092
31. Pitman JL, McGill JJ, Keegan KP, Allada R. A dynamic role for the mushroom bodies in promoting sleep in Drosophila. Nature 2006;441:753-756
32. Joiner WJ, Crocker A, White BH, Sehgal A. Sleep in Drosophila is regulated by adult mushroom bodies. Nature 2006;441:757-760
33. Hori A, Hirose G. Twin studies on parasomnias. Proceedings of the World Federation of Sleep Research Societies 1995;324:24A
34. Roth B, Buuhova S, Berkova L. Familial sleep paralysis. Schweiz Arch Neurol Neurochir Psychiatr 1968;102:321-330
35. Goode GB. Sleep paralysis. Arch Neurol 1962;6:228-234
36. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998;50:s16-s22
37. Scammell TE. The frustrating and mostly fruitless search for an autoimmune cause for narcolepsy. Sleep 2006;29:601-602
38. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-376
39. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015
40. Chemelli RM, Willie JT, Sinton C, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-451
41. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40
42. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-997
43. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-474
44. Crocker A, Espana RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 2005;65:1184-1188
45. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-1562
46. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-1020
47. Dauvilliers Y, Carlander B, Molinari N, et al. Month of birth as a risk factor for narcolepsy. Sleep 2003;26:663-665
48. Saper CB, Chou TC, Scammell TE. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci 2001;24:726-731
49. Lu J, Sherman D, Devor M, Saper CB. A putative flip-flop switch for control of REM sleep. Nature 2006;441:589-594
50. Broughton R. NREM parasomnias. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders; 2000:693-706
51. Fisher C, Kahn E, Edwards A, Davis DM. A psychophysiological study of nightmares and night terrors: I. Physiological aspects of the stage 4 night terror. J Nerv Ment Dis 1973;157:75-98
52. Mahowald M. Arousal and sleep-wake transition parasomnias. In: Lee-Chiong TL, Mahowald MW, Carskadon MA, eds. Sleep Medicine. Philadelphia: Hanley and Belfus; 2002:207-213
53. Rosen GM, Ferber R, Mahowald MW. Evaluation of parasomnias in children. Child Adolesc Psychiatr Clin N Am 1996;5:601-616
54. Mason TB II, Pack AI. Sleep terrors in childhood. J Pediatr 2005;147:388-392
55. Hallstrom T. Night terror in adults through three generations. Acta Psychiatr Scand 1972;48:350-352
56. Kales A, Soldatos CR, Bixler EO, et al. Hereditary factors in sleepwalking and night terrors. Br J Psychiatry 1980;137:111-118
57. Ooki S. Statistical genetic analysis of some problem behaviors during sleep in childhood: estimation of genetic and environmental factors influencing multiple health phenomena simultaneously. Nippon Eiseigaku Zasshi 2000;55:489-499
58. Lecendreux M, Bassetti C, Dauvilliers Y, Mayer G, Neidhart E, Tafti M. HLA and genetic susceptibility to sleepwalking. Mol Psychiatry 2003;8:114-117
59. Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Prevalence and genetics of sleepwalking: a population-based twin study. Neurology 1997;48:177-181
60. Mahowald MW, Schenck CH, Rosen GM, Hurwitz TD. The role of a sleep disorder center in evaluating sleep violence. Arch Neurol 1992;49:604-607
61. Owens J, Spirito A, Nobile C, Arrigan M. Incidence of parasomnias in children with obstructive sleep apnea. Sleep 1997;20:1193-1196
62. Goodwin JL, Kaemingk KL, Fregosi RF, et al. Parasomnias and sleep disordered breathing in Caucasian and Hispanic children: the Tucson children's assessment of sleep apnea study. BMC Med 2004;2:14
63. Guilleminault C, Palombini L, Pelayo R, Chervin RD. Sleepwalking and sleep terrors in prepubertal children: what triggers them? Pediatrics 2003;111:e17-e25
64. Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias. Neurol Clin 2005;23:1107-1126
65. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986;9:293-308
66. Sheldon SH. Parasomnias in childhood. Pediatr Clin North Am 2004;51:69-88
67. Montagna P. Sleep-related non epileptic motor disorders. J Neurol 2004;251:781-794
68. Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-851
69. Gagnon JF, Postuma RB, Mazza S, Doyon J, Montplaisir J. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006;5:424-432
70. Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 1982;239:81-105
71. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-393
72. Boeve BF, Silber MH, Ferman TJ, Lucas JA, Parisi JE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-630
73. Schapira AH. Etiology of Parkinson's disease. Neurology 2006;66(suppl 4):S10-S23
74. Ekbom KA. Restless legs: a clinical study. Acta Med Scand 1945;158:1-123
75. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless leg syndrome in adults. Arch Intern Med 2000;160:2137-2141
76. Lavigne GJ, Montplaisir J. Restless legs syndrome and sleep bruxism. Sleep 1994;17:739-743
77. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000;54:1064-1068
78. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642
79. Allen RP, Picchietti DL, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless leg syndrome diagnostic criteria, special considerations, and epidemiology. A report from the restless leg syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119
80. Desautels A, Turecki G, Montplaisir J, et al. Restless legs syndrome: confirmation of linkage to chromosome 12q, genetic heterogeneity, and evidence of complexity. Arch Neurol 2005;62:591-596
81. Ekbom KA. Restless legs syndrome. Neurology 1960;10:868-873
82. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP. Iron and the restless legs syndrome. Sleep 1998;21:371-377
83. Goodman JD, Brodie C, Ayida GA. Restless leg syndrome in pregnancy. BMJ 1988;297:1101-1102
84. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-309
85. Allen RP, Barker PB, Wehrl F, Song HK, Earley CJ. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001;56:263-265
86. Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000;54:1698-1700
87. Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res 2005;14:43-47
88. Nordlander NB. Therapy in restless legs. Acta Med Scand 1953;145:453-457
89. Earley CJ, Heckler D, Allen RP. Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome. Sleep Med 2005;6:301-305
90. Sowers JR, Vlachakis N. Circadian variation in plasma dopamine levels in man. J Endocrinol Invest 1984;7:341-345
91. Weber M, Lauterburg T, Tobler I, Burgunder JM. Circadian patterns of neurotransmitter related gene expression in motor regions of the rat brain. Neurosci Lett 2004;358:17-20
92. Clemens S, Sawchuk MA, Hochman S. Reversal of the circadian expression of tyrosine hydroxylase but not nitric oxide synthase levels in the spinal cord of dopamine D(3) knockout mice. Neuroscience 2005;133:353-357
93. Bara-Jimenez W, Aksu M, Graham B, Sato S, Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000;54:1609-1616
94. Lu J, Jhou TC, Saper CB. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray matter. J Neurosci 2006;26:193-202
95. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 2004;5:385-391
96. Desautels A, Turecki G, Montplaisir J, et al. Dopaminergic neurotransmission and restless leg syndrome: a genetic association study. Neurology 2001;57:1304-1306
97. Ambrosetto C, Lugaresi E, Coccagna G, Tasssinari CA. Clinical and polygraphic remarks in the syndrome of restless legs. Riv Patol Nerv Ment 1965;86:244-252
98. Bornstein B. Restless legs. Psychiatria et Neurologia 1961;141:165-201
99. Montagna P, Coccagna G, Ciriguotta F, Luganesi E. Familial restless legs syndrome. In: Guilleminault C, Lugaresi E, eds. Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. New York: Raven Press; 1983:231-235
100. Hening WA, Washburn T, Somel D, LeSage S, Allen RP, Earley CJ. RLS patients with younger age of onset have a higher frequency of affected relatives. Neurology 2003;60 (suppl 1):S05.004
101. Ondo WG, Vuong KD, Wang Q. Restless leg syndrome in monozygotic twins: clinical correlates. Neurology 2000;55:1404-1406
102. Trenkwalder C, Seidel VC, Gasser T, Oertel WH. Clinical symptoms and possible anticipation in a large kindred of familial restless legs syndrome. Mov Disord 1996;11:389-394
103. Lazzarini A, Walters AS, Hickey K, et al. Studies of penetrance and anticipation in five autosomal-dominant restless legs syndrome pedigrees. Mov Disord 1999;14:111-116
104. Winkelmann J, Muller-Myhsok B, Wittchen HU, et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002;52:297-302
105. Desautels A, Turecki G, Montplaisir J, Saqueira A, Verner A, Rouleau GA. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 2001;69:1266-1270
106. Walters AS, Picchietti DL, Hening WA, Lazzarini A. Variable expressivity in familial restless leg syndrome. Arch Neurol 1990;47:1219-1220
107. Kock N, Culjkovic B, Maniak S, et al. Mode of inheritance and susceptibility locus for restless legs syndrome, on chromosome 12q. Am J Hum Genet 2002;71:205-208
108. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps to chromosome 14q. Brain 2003;126:1485-1492
109. Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for restless leg syndrome on chromosome 9p. Am J Hum Genet 2004;74:876-885
110. Desautels A, Turecki G, Montplaisir J, et al. Evidence for a genetic association between monoamine oxidase A and restless leg syndrome. Neurology 2002;59:215-219
111. Gemignani F, Marbini A, Di Giovanni G, Salih S, Terzano MG. Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 1999;52:1064-1066
112. Konieczny M, Bauer P, Tomiuk J, et al. CAG repeats in restless legs syndrome. Am J Med Genet B Neuropsychiatr Genet 2006;141:173-176
113. Roth T. Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry 2005;66(suppl 9):10-13
114. Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev 2006;10:7-18
115. Fava M. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry 2004;65(suppl 16):27-32
116. Dauvilliers Y, Morin C, Cervena K, et al. Family studies in insomnia. J Psychosom Res 2005;58:271-278
117. Gambetti P, Parchi P. Insomnia in prion diseases: sporadic and familial. N Engl J Med 1999;340:1675-1677
118. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363-13383
119. Dauvilliers Y, Cervena K, Carlander B, et al. Dissociation in circadian rhythms in a pseudohypersomnia form of fatal familial insomnia. Neurology 2004;63:2416-2418
120. Lugaresi E, Medori R, Baruzzi A, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997-1003
121. Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathologic study of 5 new cases. Neurology 1992;42:312-319
122. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806-808
123. Montagna P, Cortelli P, Avoni P, et al. Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol 1998;8:515-520
124. Mastrianni JA, Nixon R, Layzer R, et al. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999;340:1630-1638
125. Parchi P, Capellari S, Chin S, et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology 1999;52:1757-1763
126. Landolt HP, Glatzel M, Blattler T, et al. Sleep-wake disturbances in sporadic Creutzfeldt-Jakob disease. Neurology 2006;66:1418-1424
127. Tobler I, Deboer T, Fischer M. Sleep and sleep regulation in normal and prion protein-deficient mice. J Neurosci 1997;17:1869-1879
128. Bazil CW. Nocturnal seizures. Semin Neurol 2004;24:293-300
129. Herman ST, Walczak TS, Bazil CW. Distribution of partial seizures during the sleep-wake cycle: differences by seizure onset site. Neurology 2001;56:1453-1459
130. Malow BA, Weatherwax KJ, Chervin RD, et al. Identification and treatment of obstructive sleep apnea in adults and children with epilepsy: a prospective pilot study. Sleep Med 2003;4:509-515
131. Malow BA. Sleep deprivation and epilepsy. Epilepsy Curr 2004;4:193-195
132. Vadlamudi L, Kjeldsen MJ, Corey LA, et al. Analyzing the etiology of benign Rolandic epilepsy: a multicenter twin collaboration. Epilepsia 2006;47:550-555
133. Provini F, Plazzi G, Tinuper P, Vandi S, Lugaresi E, Montagna P. Nocturnal frontal lobe epilepsy, a clinical and polygraphic overview of 100 consecutive cases. Brain 1999;122:1017-1031
134. Provini F, Plazzi G, Lugaresi E. From nocturnal paroxysmal dystonia to nocturnal frontal lobe epilepsy. Clin Neurophysiol 2000;111(suppl 2):S2-S8
135. Hirose S, Iwata H, Akiyoshi H, et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology 1999;53:1749-1753
136. De Fusco M, Becchetti A, Patrignani A, et al. The nicotinic receptor beta 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 2000;26:275-276
137. Bertrand D, Picard F, Le Hellard S, et al. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia 2002;43(suppl 5):112-122
138. Combi R, Dalpra L, Ferini-Strambi L, Tenchini ML. Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene. Ann Neurol 2005;58:899-904
139. Pack AI. Advances in sleep-disordered breathing. Am J Respir Crit Care Med 2006;173:7-15
140. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235
141. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-1239
142. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 2004;291:2013-2016
143. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163:608-613
144. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015-3021
145. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002;359:204-210
146. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-73
147. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-916
148. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-1053
149. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676
150. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-682
151. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004;160:521-530
152. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447-452
153. Strohl KP, Saunders NA, Feldman NT, Hallett M. Obstructive sleep apnea in family members. N Engl J Med 1978;299:969-973
154. Redline S, Tosteson T, Tishler PV, Carskadon MA, Millman RP. Studies in the genetics of obstructive sleep apnea: familial aggregation of symptoms associated with sleep-related breathing disturbances. Am Rev Respir Dis 1992;145:440-444
155. Redline S, Tishler PV, Tosteson TD, et al. The familial aggregation of obstructive sleep apnea. Am J Respir Crit Care Med 1995;151:682-687
156. Mathur R, Douglas NJ. Family studies in patients with the sleep apnea-hypopnea syndrome. Ann Intern Med 1995;122:174-178
157. Pillar G, Lavie P. Assessment of the role of inheritance in sleep apnea syndrome. Am J Respir Crit Care Med 1995;151:688-691
158. Gislason T, Johannsson JH, Haraldsson A, et al. Familial predisposition and cosegregation analysis of adult obstructive sleep apnea and the sudden infant death syndrome. Am J Respir Crit Care Med 2002;166:833-838
159. Schwab RJ. Genetic determinants of upper airway structures that predispose to obstructive sleep apnea. Respir Physiol Neurobiol 2005;147:289-298
160. Schwab RJ, Arens R, Pack A. Sleep apnea. In: Lipson DA, van Beek EJR, eds. Functional Lung Imaging. Vol. 200: Lung Biology in Health and Disease. Boca Raton: Taylor and Francis; 2005:513-557
161. Horner RL, Mohiaddin RH, Lowell DG, et al. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 1989;2:613-622
162. Miles PG, Vig PS, Weyant RJ, Forrest TD, Rockette HE Jr. Craniofacial structure and obstructive sleep apnea syndrome: a qualitative analysis and meta-analysis of the literature. Am J Orthod Dentofacial Orthop 1996;109:163-172
163. Lowe AA, Fleetham JA, Adachi S, Ryan CF. Cephalometric and computed tomographic predictors of obstructive sleep apnea severity. Am J Orthod Dentofacial Orthop 1995;107:589-595
164. Guilleminault C, Partinen M, Hollman K, Powell N, Stoohs R. Familial aggregates in obstructive sleep apnea syndrome. Chest 1995;107:1545-1551
165. Schwab RJ, Pasirstein M, Pierson R, et al. Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 2003;168:522-530
166. Schwab RJ, Pasirstein M, Kaplan L, et al. Family aggregation of upper airway soft tissue structures in normal subjects and patients with sleep apnea. Am J Respir Crit Care Med 2006;173:453-463
167. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet 2005;6:221-234
168. Stunkard AJ, Foch TT, Hrubec Z. A twin study of human obesity. JAMA 1986;256:51-54
169. Sorensen TI, Price RA, Stunkard AJ, Schulsinger F. Genetics of obesity in adult adoptees and their biological siblings. BMJ 1989;298:87-90
170. Borecki IB, Rice T, Perusse L, Bouchard C, Rao DC. An exploratory investigation of genetic linkage with body composition and fatness phenotypes: the Quebec Family Study. Obes Res 1994;2:213-219
171. Borecki IB, Rice T, Perusse L, Bouchard C, Rao DC. Major gene influence on the propensity to store fat in trunk versus extremity depots: evidence from the Quebec Family Study. Obes Res 1995;3:1-8
172. Rice T, Perusse L, Bouchard C, Rao DC. Familial clustering of abdominal visceral fat and total fat mass: the Quebec Family Study. Obes Res 1996;4:253-261
173. Kadotani H, Kadotani T, Young T, et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001;285:2888-2890
174. Gottlieb DJ, DeStefano AL, Foley DJ, et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology 2004;63:664-668
175. Foley DJ, Masaki K, White L, Redline S. Relationship between apolipoprotein E epsilon4 and sleep-disordered breathing at different ages. JAMA 2001;286:1447-1448
176. Saarelainen S, Lehtimaki T, Kallonen E, Laasonen K, Poussa T, Nieminen MM. No relation, between apolipoprotein E alleles and obstructive sleep apnea. Clin Genet 1998;53:147-148
177. Larkin EK, Patel SR, Redline S, Mignot E, Elston RC, Hallmayer J. Apolipoprotein E and obstructive sleep apnea: evaluating whether a candidate gene explains a linkage peak. Genet Epidemiol 2006;30:101-110
178. O'Hara R, Schroder CM, Kraemer HC, et al. Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers. Neurology 2005;65:642-644
179. Sakai K, Takada T, Nakayama H, et al. Serotonin-2A and 2C receptor gene polymorphisms in Japanese patients with obstructive sleep apnea. Intern Med 2005;44:928-933
180. Riha RL, Brander P, Vennelle M, et al. Tumour necrosis factor-alpha (-308) gene polymorphism in obstructive sleep apnoea-hypopnoea syndrome. Eur Respir J 2005;26:673-678
181. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP. Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 2004;89:4409-4413
182. Palmer LJ, Buxbaum SG, Larkin E, et al. A whole-genome scan for obstructive sleep apnea and obesity. Am J Hum Genet 2003;72:340-350
183. Palmer LJ, Buxbaum SG, Larkin EK, et al. Whole genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004;169:1314-1321
184. Buxbaum SG, Elston RC, Tishler PV, Redline S. Genetics of the apnea hypopnea index in Caucasians and African Americans: I. Segregation analysis. Genet Epidemiol 2002;22:243-253
185. Ginsburg GS, Donahue MP, Newby LK. Prospects for personalized cardiovascular medicine: the impact of genomics. J Am Coll Cardiol 2005;46:1615-1627